| The associations between sleep and externalizing and internalizing problems in children and adolescents with attention-deficit/hyperactivity disorder: empirical findings … J Dimakos, G Gauthier-Gagné, L Lin, S Scholes, R Gruber Child and Adolescent Psychiatric Clinics 30 (1), 175-193, 2021 | 21 | 2021 |
| Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study J Dimakos, Y Cui, RW Platt, C Renoux, KB Filion, A Douros Diabetes Care 46 (2), 377-383, 2023 | 5 | 2023 |
| Effectiveness and safety of direct oral anticoagulants among octogenarians with venous thromboembolism: an international multidatabase cohort study A Douros, F Basedow, Y Cui, J Dimakos, J Walker, D Enders, V Tagalakis The American Journal of Medicine 136 (1), 79-87. e7, 2023 | 4 | 2023 |
| Concomitant use of sulfonylureas and warfarin and the risk of severe hypoglycemia: population-based cohort study J Dimakos, Y Cui, RW Platt, C Renoux, KB Filion, A Douros Diabetes Care 45 (10), e131-e133, 2022 | 3 | 2022 |
| Gender differences in sleep hygiene associated with poor sleep in adolescents with adhd symptoms J Dimakos, G Somerville, C Finn, J Boursier, D Keskinel, R Gruber Sleep Medicine 64, S137-S138, 2019 | 1 | 2019 |
| Methodological Considerations on the Use of Cohort Designs in Drug-Drug Interaction Studies in Pharmacoepidemiology J Dimakos, A Douros Current Epidemiology Reports, 1-9, 2024 | | 2024 |
| FLUOROQUINOLONES AND THE RISK OF SEVERE HYPOGLYCEMIA AMONG SULFONYLUREA USERS: POPULATION-BASED COHORT STUDY J Dimakos, Y Cui, K Filion, C Renoux, R Platt, A Douros Canadian Journal of Diabetes 47 (7), S103, 2023 | | 2023 |
| Pharmacologic Heterogeneity and Risk of Severe Hypoglycemia with Concomitant Use of Sulfonylureas and DPP‐4 Inhibitors: Population‐Based Cohort Study J Dimakos, Y Cui, RW Platt, C Renoux, KB Filion, A Douros Clinical Pharmacology & Therapeutics 114 (3), 712-720, 2023 | | 2023 |
| A population based assessment of concomitant use of sulfonylureas and beta-blockers and the risk of severe hypoglycemia J Dimakos, Y Cui, R Platt, K Filion, C Renoux, A Douros PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 308-308, 2022 | | 2022 |
| Peptidomimetic structure of dipeptidyl peptidase-4 inhibitors and the risk of sulfonylurea-induced severe hypoglycemia: a population-based cohort study J Dimakos, Y Cui, R Platt, C Renoux, K Filion, A Douros PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 286-286, 2022 | | 2022 |
| 1136-P: A Population-Based Assessment of the Risk of Severe Hypoglycemia with Concomitant Use of Sulfonylureas and Peptidomimetic Dipeptidyl Peptidase-4 Inhibitors J Dimakos, Y Cui, RW Platt, C Renoux, KB Filion, A Douros Diabetes 71 (Supplement_1), 2022 | | 2022 |
| Concomitant use of sulfonylureas and beta-blockers and the risk of severe hypoglycemia: Population-based cohort study J Dimakos, Y Cui, RW Platt, C Renoux, BK Filion, A Douros Journal of Hypertension 40 (Suppl 1), e193, 2022 | | 2022 |
| Sleep and Attention-Deficit/Hyperactivity Disorder J Dimakos, LM Giorgio, R Gruber Sleep and Neuropsychiatric Disorders, 523-542, 2022 | | 2022 |
| 0217 Adolescents’ Evening Preference is Associated with Specific Sleep Hygiene Behaviours G Gauthier-Gagne, J Dimakos, G Somerville, J Boursier, R Gruber Sleep 43, A84, 2020 | | 2020 |
| 0328 The Associations Between Self-Reported Symptoms of Sleep Disorders, Objective Sleep Patterns and Affect in Adolescence J Dimakos, G Gauthier-Gagne, G Somerville, J Boursier, R Gruber Sleep 43, A124-A125, 2020 | | 2020 |
| 77 Sleep Behaviours and Disturbances Characterizing Adolescents with ADHD Symptoms J Dimakos, G Somerville, C Finn, D Keskinel, A Ionescu, C Toro, ... Paediatrics & Child Health 24, e30, 2019 | | 2019 |
